{
  "timestamp": "2026-02-01T17:21:13.870345",
  "queries": 3,
  "harness_version": "2.0",
  "baseline": {
    "mode": "baseline",
    "timestamp": "2026-02-01T17:22:25.987462",
    "total_queries": 3,
    "successful": 1,
    "failed": 2,
    "suspect": 0,
    "avg_latency_ms": 24708.0,
    "not_found_rate": 1.0,
    "avg_verified_citations": 0.0,
    "avg_unverified_citations": 0.0,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.0,
    "avg_candidates_added": 0.0,
    "avg_phase1_latency_ms": 0.0,
    "avg_answer_length": 316.0,
    "results": [
      {
        "run_id": "error_eval_multi_issue_101_112_a_1769966474_afb1336d",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769966474_afb1336d",
        "success": false,
        "error": "'NoneType' object has no attribute 'get'",
        "latency_ms": 21361,
        "generated_at": "2026-02-01T17:21:36.173559",
        "verified_citations": "unknown",
        "unverified_citations": "unknown",
        "not_found": "unknown",
        "scotus_present": "unknown",
        "en_banc_present": "unknown",
        "answer_length": 0,
        "phase1_triggered": false,
        "candidates_added": 0,
        "triggers": [],
        "phase1_latency_ms": 0
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769966496_ee0687e4",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769966496_ee0687e4",
        "success": true,
        "generated_at": "2026-02-01T17:22:01.684450",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 24708,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "error_eval_multi_issue_103_112_1769966522_6501be7f",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769966522_6501be7f",
        "success": false,
        "error": "'NoneType' object has no attribute 'get'",
        "latency_ms": 23300,
        "generated_at": "2026-02-01T17:22:25.486337",
        "verified_citations": "unknown",
        "unverified_citations": "unknown",
        "not_found": "unknown",
        "scotus_present": "unknown",
        "en_banc_present": "unknown",
        "answer_length": 0,
        "phase1_triggered": false,
        "candidates_added": 0,
        "triggers": [],
        "phase1_latency_ms": 0
      }
    ]
  },
  "phase1": {
    "mode": "phase1",
    "timestamp": "2026-02-01T17:23:41.155364",
    "total_queries": 3,
    "successful": 3,
    "failed": 0,
    "suspect": 0,
    "avg_latency_ms": 24206.0,
    "not_found_rate": 0.3333333333333333,
    "avg_verified_citations": 3.3333333333333335,
    "avg_unverified_citations": 0.0,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.6666666666666666,
    "avg_candidates_added": 0.6666666666666666,
    "avg_phase1_latency_ms": 563.6666666666666,
    "avg_answer_length": 4743.333333333333,
    "results": [
      {
        "run_id": "64e9dfee-b685-40e2-a712-f135115c5df3",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769966545_d07f17e0",
        "success": true,
        "generated_at": "2026-02-01T17:22:43.571308",
        "final_answer_text": "The requirements for patent eligibility under **35 U.S.C. \u00a7 101** (as interpreted by the Supreme Court in *Alice Corp. v. CLS Bank International*) and the written description requirement under **35 U.S.C. \u00a7 112(a)** are distinct and governed by different legal standards. Below is a breakdown of each:\n\n---\n\n### **Patent Eligibility under 35 U.S.C. \u00a7 101 (Alice Framework)**\n\nThe *Alice* decision established a two-step framework for determining whether a claim is patent-eligible under \u00a7 101:\n\n1. **",
        "answer_length": 6055,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 17195,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 781,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769966564_47cc83d9",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769966564_47cc83d9",
        "success": true,
        "generated_at": "2026-02-01T17:23:12.169761",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 27796,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "5b96bbed-38bb-4cc6-ba35-d083a98aa1ca",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769966592_515a10dd",
        "success": true,
        "generated_at": "2026-02-01T17:23:40.654374",
        "final_answer_text": "## Immediate Answer:\nObviousness analysis and written description requirements for genus claims differ in their focus and purpose. Obviousness analysis under 35 U.S.C. \u00a7 103 evaluates whether the claimed invention as a whole would have been obvious to a person of ordinary skill in the art at the time of invention, based on the prior art. In contrast, the written description requirement under 35 U.S.C. \u00a7 112, \u00b6 1 ensures that the patent specification adequately demonstrates that the inventor was ",
        "answer_length": 7859,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 27627,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 910,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      }
    ]
  },
  "comparison": {
    "baseline": {
      "total_queries": 3,
      "successful": 1,
      "avg_latency_ms": 24708.0,
      "not_found_rate": 1.0,
      "avg_verified_citations": 0.0,
      "scotus_coverage": 0.0
    },
    "phase1": {
      "total_queries": 3,
      "successful": 3,
      "avg_latency_ms": 24206.0,
      "not_found_rate": 0.3333333333333333,
      "avg_verified_citations": 3.3333333333333335,
      "scotus_coverage": 0.0,
      "phase1_trigger_rate": 0.6666666666666666,
      "avg_candidates_added": 0.6666666666666666
    },
    "deltas": {
      "latency_delta_ms": -502.0,
      "not_found_delta": -0.6666666666666667,
      "verified_citations_delta": 3.3333333333333335,
      "scotus_coverage_delta": 0.0
    },
    "improvements": {
      "reduced_not_found": true,
      "more_verified_citations": true,
      "better_scotus_coverage": true
    }
  }
}